ISSCR Statement Regarding the Marketing of Unproven Stem Cell Treatments for COVID-19

ISSCR has become aware of recent claims that stem cells can be used to treat people infected with COVID-19. While stem cell research shows promise for numerous diseases and conditions, there currently are no approved stem cell-based approaches for the prevention and treatment of COVID-19 infection. The ISSCR is a vocal and active opponent of the premature

Read More


How to stay safe, informed amid rise in e-mail scams and fake news on Novel Coronavirus

As concern over the deadly coronavirus grows, fake news and scams capitalising on people’s fears are also spreading. On February the 8th confirmed data on Coronavirus 2019-nCoV Global Cases by Johns Hopkins CSSE dashboard early 34,600 people have been infected and more than 700 have died in China, with the majority of the cases in Hubei province. Outside

Read More


Rogue stem cell clinics

Cell therapies hold significant promise for the treatment of injured or diseased musculoskeletal tissues. However, despite advances in research, there is growing concern about the increasing number of clinical centres around the world that are making unwarranted claims or are performing risky biological procedures. On The Bone and Joint Journal has just been published a

Read More


ISSCR Statement on Ethical Standards for Stem Cell-based Embryo Models

The ISSCR is updating its Guidelines for Stem Cell Research and Clinical Translation to respond to recent scientific advances that include the use of pluripotent stem cell (PSC) to create models of early human embryo development (see Stem Cell Reports 14:1-6). As the science continues to advance, it raises important scientific, clinical, ethical, and societal issues for researchers,

Read More


Court of Justice upholds EMA’s approach to transparency

EMA welcomes today’s two appellate judgments by the Court of Justice1 that confirmed, in clear and unambiguous terms, the right of citizens for access to clinical study and toxicology reports submitted to EMA for the purpose of the granting of a marketing authorisation for human and veterinary medicinal products. Source EMA “Transparency is an important feature of the Agency’s

Read More


BBC journalist discovers a new stem cell clinic in London which offers to ‘treat’ children with autism for £9,500 a time.

Prof Murphy, leading authority on autism research at Kings College Hospital, says he is horrified that such a treatment is being offered. Lesley Curwen investigates the scientific promise of human stem cells, cells with superpowers that can become many different types of cells in our bodies from muscle cells to brain cells. Some can even

Read More


European Commission publishes new documents regarding the Clinical Trials Regulation

Shortly after updating the related draft Questions and Answers document, the European Commission has published two new documents concerning the Clinical Trials Regulation (EU) 536/2014. The first document is an informed consent and patient recruitment procedure template. The second document is an updated clinical trial Application Form. 2. Recruitment and Informed consent procedure template This draft template was developed

Read More